At baseline, patients in the intervention phase had lower incidence of chronic kidney disease, encephalopathy and upper digestive hemorrhage, lower preoperative levels of creatinine and urea and higher levels of albumin (Table 1). The gene discussed is ALB; the disease is Encephalopathy.